Oxford Biomedica

Oxford Biomedica's reported carbon emissions

Oxford Biomedica (GB), a biological product manufacturing company, has reported its carbon emissions for several years, with the most recent data available for 2025. In 2025, the company's total emissions were approximately 66.3 million kg CO2e. This total comprises Scope 1 emissions of about 2.4 million kg CO2e, Scope 2 emissions of roughly 1.3 million kg CO2e (market-based), and significant Scope 3 emissions amounting to approximately 62.5 million kg CO2e. Purchased goods and services were the largest contributor within Scope 3. For 2024, total emissions were approximately 83.9 million kg CO2e, with Scope 1 at about 2.4 million kg CO2e, Scope 2 at approximately 1.7 million kg CO2e (market-based), and Scope 3 at nearly 80 million kg CO2e. In 2023, total emissions were approximately 57.6 million kg CO2e, including Scope 1 emissions of around 3.4 million kg CO2e, Scope 2 of about 1.5 million kg CO2e (market-based), and Scope 3 emissions of approximately 52.7 million kg CO2e. The company has set ambitious climate commitments. Notably, Oxford Biomedica aims for an absolute reduction in Scope 1 and 2 emissions of 42% by 2030, using 2021 as a baseline year. They have also committed to increasing their sourcing of renewable electricity to 100% by 2030. Furthermore, they are working towards ensuring that 90% of their suppliers, by emissions covering purchased goods and services, will have science-based targets by 2029. There are also indications of a net-zero commitment by 2050.